Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.66 |
| ▸ | GFER | P55789 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | PREP | P48147 | 2/20 | 0.62 |
| ▸ | CTSK | P43235 | 1/20 | 0.62 |
| ▸ | PRCP | P42785 | 1/20 | 0.62 |
| ▸ | KDM1A | O60341 | 1/20 | 0.61 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8426716 | 1.00 | NPSR1 (0.68) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL26477642 | 1.00 | NPSR1 (0.68) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL10154053 | 0.96 | NPSR1 (0.64) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL9564582 | 0.88 | CTRB1 (0.70) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL7265570 | 0.88 | CTRB1 (0.70) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL10952307 | 0.88 | PRCP (0.68) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL8248799 | 0.88 | CTRB1 (0.73) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL8247594 | 0.88 | CTRB1 (0.73) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL8395473 | 0.88 | CTRB1 (0.73) | NPSR1TSHRL3MBTL1KDM4ELMNA | |
| SCHEMBL13958801 | 0.88 | NPSR1 (0.66) | NPSR1TSHRL3MBTL1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026085629-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Université de Montréal (CA) | 2026-04-30 | — | — | WO | disclosed |
| US-7504431-B2 | Sulfonyl amide inhibitors of calcium channel function | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-03-17 | — | — | US | disclosed |
| US-20050245535-A1 | Sulfonyl amide inhibitors of calcium channel function | BRISTOL- MYERS SQUIBB COMPANY | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245535-A1 | Sulfonyl amide inhibitors of calcium channel function | CACNA1F, CACNA1A, CACNA1D | NPSR1 770/4885TSHR 1902/4885L3MBTL1 4216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.